Exhibit with us
*mymedicalexpo  
English
  1. Catalogs
  2. MagVenture
  3. MagVita TMS Therapy®

MagVita TMS Therapy®

MagVita TMS Therapy®
1 / 4 PagesView full catalog

MagVita TMS Therapy®

Product catalog summary
Overview: The document discusses MagVita TMS Therapy®, a CE-approved treatment for Major Depressive Disorder (MDD) using repetitive Transcranial Magnetic Stimulation (rTMS). It is presented as an effective, non-invasive alternative to antidepressants, particularly for patients who do not respond to medication or cannot tolerate its side effects.
Specifications: rTMS involves delivering magnetic pulses through a coil to stimulate nerve cells in the brain's mood-controlling region. This stimulation increases blood flow, glucose metabolism, and neurotransmitter levels, which are typically reduced in depressed individuals.
Clinical Efficacy: Clinical trials indicate a high response and remission rate, with a meta-analysis showing a 55% effect size for rTMS compared to 17-46% for pharmacotherapy. A double-blind trial reported a 61% response rate with significant HAM-D score reduction over four weeks.
Indications: MagVita TMS Therapy® is approved for adults with MDD who have not improved with two prior antidepressant medications. The treatment is outpatient, does not require anesthesia, and allows patients to resume daily activities immediately.
Treatment Protocol: The therapy involves an initial session to determine the patient's stimulation level, followed by five sessions per week over 4-6 weeks. Maintenance treatment may be necessary. The procedure is simple, requiring only patient positioning, protocol setting, and starting the treatment.
Side Effects: Common side effects include transient headaches, but the therapy is free from typical antidepressant side effects like nausea, sexual dysfunction, and weight gain.
Implementation: MagVenture offers solutions suitable for various clinic sizes, with easy-to-use systems that include pre-defined protocols and tools for accurate treatment spot determination.
Conclusion: MagVita TMS Therapy® is a promising alternative for treating MDD, offering significant benefits over traditional antidepressants, especially for treatment-resistant patients.
See more

Catalog excerpts

MagVita TMS Therapy®-1

Effective treatment of Major Depressive Disorder – an alternative to antidepressants – a CE-approved therapy based on repetitive Transcranial Magnetic Stimulation (rTMS) Please note that this brochure is not intended for US audiences.

 Open the catalog to page 1
MagVita TMS Therapy®-2

What is repetitive Transcranial Magnetic Stimulation (rTMS)? Indications for use MagVita TMS Therapy® is CE-approved for “treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from two prior antidepressant medications, at or above the minimal effective dose and duration in the current episode”. Excellent response and remission rate rTMS is an effective, non-invasive, and pain free*) alternative for the large number of patients not responding to medication or who cannot tolerate the side effects of medication. rTMS does not require anesthesia...

 Open the catalog to page 2
MagVita TMS Therapy®-3

Why you should offer MagVita TMS Therapy® to your patients Anti‑ depressants Anxiety Blurred vision Feeling sick Sexual dysfunction Weight gain Often patients suffering from major depression obtain no relief, or inadequate relief from antidepressants. In many cases, drug therapies induce side effects that result in noncompliance. MagVita TMS Therapy® based on repetitive Transcranial Magnetic Stimulation (rTMS) is an effective and easy-to-use alternative: • Series of pulsed magnetic stimuli to the brain • Non-invasive procedure – no anesthetics ­ • Outpatient treatment • Excellent tolerability...

 Open the catalog to page 3
MagVita TMS Therapy®-4

Get more information Contact us for more information if you consider offering rTMS depression treatment to your patients. You can also find more information about the MagVita TMS Therapy® system on www.magventure.com. Please note that this brochure is not intended for US audiences. Sources 1. Slotema et al., 2010, ”Should We Expand the Toolbox of Psychiatric Treatment Methods to Include Repetitive Transcranial Magnetic Stimulation (rTMS)? - A Meta-Analysis of the Efficacy of rTMS in Psychiatric Disorders”. The Journal of Clinical Psychiatry. 2. National Institute of Mental Health (www.nimh.nih.gov)...

 Open the catalog to page 4

All MagVenture catalogs and technical brochures

  1. MagVenture TMS Therapy® practice
    MagVenture TMS Therapy® practice

    2  Pages

  2. MagVenture TMS Therapy
    MagVenture TMS Therapy

    4  Pages

  3. MagPro R20
    MagPro R20

    1  Page

  4. MagPro R30
    MagPro R30

    1  Page

  5. MagPro X100
    MagPro X100

    1  Page

  6. MAGPRO R30
    MAGPRO R30

    1  Page

  7. TREATMENT CHAIR
    TREATMENT CHAIR

    1  Page

  8. MagPro® by MagVenture®
    MagPro® by MagVenture®

    6  Pages

  9. MagPro® R20
    MagPro® R20

    2  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.